News - Northern Europe, Rare diseases

Filter

Popular Filters

FDA grants priority review for Genzyme’s Cerdelga

FDA grants priority review for Genzyme’s Cerdelga

11-12-2013

The US Food and Drug Administration has granted Sanofi (Euronext: SAN) and its subsidiary Genzyme a six-month…

BiotechnologyeliglustatGenzymeNorthern EuropeRare diseasesResearch

Back to top